• M S Jarvis, J Blackburn, C Hailstone, C L Small, C Dixon, W Rook, R Maniar, J Graham, T Sengar, S J Dunn, L Tooley, E Blurton, K Mak, R Dunham, R Baker, V Lacey, N Basheer, A Freeman, S Delahunt, S Gurung, N Akhtar, R Parmar, D Whitney, L Shatananda, C Wallengren, J Pilsbury, D Cochran, N Sandur, V Girotra, J Greenwood, D Baines, B Olojede, A Bhat, L Baxendale, M Porter, A Whapples, A Kumar, M Ramamoorthy, R Perry, and L Magill.
• University Hospitals of North Midlands NHS Trust, UK. Electronic address: michaeljarvis@nhs.net.
• Int J Obstet Anesth. 2023 Aug 1; 55: 103899103899.

BackgroundSpinal anaesthesia, the most common form of anaesthesia for caesarean section, leads to sympathetic blockade and profound maternal hypotension resulting in adverse maternal and neonatal outcomes. Hypotension, nausea and vomiting remain common but until the publication of the National Institute of Health and Care Excellence (NICE) 2021 guidance, no national guideline existed on how best to manage maternal hypotension following spinal anaesthesia for caesarean section. A 2017 international consensus statement recommended prophylactic vasopressor administration to maintain a systolic blood pressure of >90% of an accurate pre-spinal value, and to avoid a drop to <80% of this value. This survey aimed to assess regional adherence to these recommendations, the presence of local guidelines for management of hypotension during caesarean section under spinal anaesthesia, and the individual clinician's treatment thresholds for maternal hypotension and tachycardia.MethodsThe West Midlands Trainee-led Research in Anaesthesia and Intensive Care Network co-ordinated surveys of obstetric anaesthetic departments and consultant obstetric anaesthetists across 11 National Health Service Trusts in the Midlands, England.ResultsOne-hundred-and-two consultant obstetric anaesthetists returned the survey and 73% of sites had a policy for vasopressor use; 91% used phenylephrine as the first-line drug but a wide range of recommended delivery methods was noted and target blood pressure was only listed in 50% of policies. Significant variation existed in both vasopressor delivery methods and target blood pressures.ConclusionsAlthough NICE has since recommended prophylactic phenylephrine infusion and a target blood pressure, the previous international consensus statement was not adhered to routinely.Copyright © 2023 Elsevier Ltd. All rights reserved.

30 keywords...

hide…